![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » PAREXEL SIGNS JV WITH SYNCHRON RESEARCH
PAREXEL SIGNS JV WITH SYNCHRON RESEARCH
July 11, 2006
Parexel International Corporation, a biopharmaceutical outsourcing organizations, has entered into a joint venture (JV) arrangement with Synchron Research Services Private Limited, pursuant to which it purchased a majority stake in a newly formed entity called Parexel International Synchron Private Limited into which Synchron transferred its clinical trial business operations located in Bangalore, India.
Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=34179§ionid=)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct